NIH-funded research R03 grant

Understanding how Hedgehog signaling affects gene activation in development and cancer.

Official title: Hedgehog signal transduction: mechanism of Ci/Gli transcriptional effector activation

Funded at Columbia Univ New York Morningside · NIH-10809872 · Data updated 2026-11-12

This study is looking at how a specific signaling pathway in our cells, called the Hedgehog pathway, works and how problems with it can lead to developmental disorders and cancers, using fruit flies to help us understand these issues better and find new treatments.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionColumbia Univ New York Morningside
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 3, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$152,226
NIH project number1R03HD111663-01A1
Project IDNIH-10809872 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with cancers or developmental disorders associated with Hedgehog signaling mutations.

Less likely to help

Patients with conditions unrelated to Hedgehog signaling or those not affected by genetic mutations in this pathway may not benefit from this research.

What this research studies

This research investigates the Hedgehog (Hh) signaling pathway, which plays a crucial role in development and stem cell regulation in both fruit flies and humans. By studying the molecular mechanisms that activate transcription factors involved in this pathway, the research aims to uncover how genetic changes can lead to developmental disorders and various cancers. The approach involves using Drosophila as a model organism to explore the connections between key proteins in the signaling pathway, which could lead to the development of targeted therapies for conditions caused by Hh signaling disruptions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for cancers and developmental disorders linked to Hedgehog signaling abnormalities.

How similar studies have gone: Previous research has shown promising results in targeting components of the Hedgehog signaling pathway for cancer treatment, indicating that this approach has potential for success.

Where this research is happening

  • Columbia Univ New York Morningside
    New York, United States
    Active

Researchers

  • Principal investigator: Kalderon, Daniel D — Columbia Univ New York Morningside
  • Study coordinator: Kalderon, Daniel D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.